PROVID PHARMACEUTICALS INC.
Patent Owner
Stats
- 8 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Mar 14, 2017 most recent publication
Details
- 8 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 75 Total Citation Count
- Feb 13, 2004 Earliest Filing
- 1 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9278089 Method of treating HCV infection with a small molecule CHK2 inhibitorOct 26, 12Mar 08, 16[A61K, C07D, C12N]
9265765 7-benzyl-10-(2-methylbenzyl)-2,6,7,8,9,10-hexahydroimidazo[1,2-A]pyrido[4,3-D]pyrimidin-5(3H)-one, salts thereof and methods of using the same in combination therapyMar 13, 14Feb 23, 16[A61K]
8765802 Kinase inhibitors, compositions thereof, and methods of use therewithJun 09, 08Jul 01, 14[A61K, C07D]
8598312 Inhibitors of antigen presentation by MHC class II moleculesJun 15, 12Dec 03, 13[A61K, C07K]
8222215 Methods for the use of inhibitors of antigen presentation by MHC class II moleculesSep 05, 08Jul 17, 12[A61K]
7439231 Inhibitors of antigen presentation by MHC class II molecules and methods of use thereofFeb 13, 04Oct 21, 08[A61K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2011/0217,324 INHIBITORS OF ANTIGEN PRESENTATION BY MHC CLASS II MOLECULES AND METHODS OF USE THEREOFAbandonedDec 02, 08Sep 08, 11[A61K, C12N, A61P, C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.